Non-Invasive Methods to Monitor Mechanisms of Resistance to Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer: Where Do We Stand?

By Ulivi Paola  

International Journal of Molecular Sciences, Vol. 17, Iss. 7, 2016-07 ,pp. : 1186-1186

MDPI

Access to resources Recommend Favorite

Hypertension Caused by Lenvatinib and Everolimus in the Treatment of Metastatic Renal Cell Carcinoma

By Bendtsen Mathias Alrø Fichtner   Grimm Daniela   Bauer Johann   Wehland Markus   Wise Petra   Magnusson Nils E.   Infanger Manfred   Krüger Marcus  

International Journal of Molecular Sciences, Vol. 18, Iss. 8, 2017-08 ,pp. : 1736-1736

MDPI

Access to resources Recommend Favorite

The Adverse Effect of Hypertension in the Treatment of Thyroid Cancer with Multi-Kinase Inhibitors

By Ancker Ole Vincent   Wehland Markus   Bauer Johann   Infanger Manfred   Grimm Daniela  

International Journal of Molecular Sciences, Vol. 18, Iss. 3, 2017-03 ,pp. : 625-625

MDPI

Access to resources Recommend Favorite

Concurrent Autophagy Inhibition Overcomes the Resistance of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Human Bladder Cancer Cells

By Kang Minyong   Lee Kyoung-Hwa   Lee Hye Sun   Jeong Chang Wook   Kwak Cheol   Kim Hyeon Hoe   Ku Ja Hyeon  

International Journal of Molecular Sciences, Vol. 18, Iss. 2, 2017-02 ,pp. : 321-321

MDPI

Access to resources Recommend Favorite

Tyrosine Kinase Inhibitors as Antiangiogenic Drugs in Multiple Myeloma

By Ribatti Domenico  

Pharmaceuticals, Vol. 3, Iss. 4, 2010-04 ,pp. : 1225-1231

MDPI

Access to resources Recommend Favorite